
专业SGLT2抑制剂心力衰竭
达格列净与螺内酯:治疗射血分数保留的心力衰竭的有希望组合
By MedXY|2025年10月3日
SOGALDI-PEF试验评估了达格列净联合螺内酯与单独使用达格列净在心力衰竭患者中的效果,显示NT-proBNP水平显著改善和安全性问题。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.